dc.contributor.author
Benejam, Bessy
dc.contributor.author
Videla, Laura
dc.contributor.author
Vilaplana, Eduard
dc.contributor.author
Barroeta, Isabel
dc.contributor.author
Carmona Iragui, María
dc.contributor.author
Altuna, Miren
dc.contributor.author
Valldeneu, Silvia
dc.contributor.author
Fernández, Susana
dc.contributor.author
Giménez, Sandra
dc.contributor.author
Iulita, Maria Florencia
dc.contributor.author
Garzón, Diana
dc.contributor.author
Bejanin, Alexandre
dc.contributor.author
Bartrés Faz, David
dc.contributor.author
Videla, Sebastià
dc.contributor.author
Alcolea, Daniel
dc.contributor.author
Blesa González, Rafael
dc.contributor.author
Lleó Bisa, Alberto
dc.contributor.author
Fortea, Juan
dc.date.issued
2023-03-17T13:53:06Z
dc.date.issued
2023-03-17T13:53:06Z
dc.date.issued
2020-05-25
dc.date.issued
2023-03-17T13:53:06Z
dc.identifier
https://hdl.handle.net/2445/195526
dc.description.abstract
Introduction: We aimed to define prodromal Alzheimer's disease (AD) and AD dementia using normative neuropsychological data in a large population-based cohort of adults with Down syndrome (DS). Methods: Cross-sectional study. DS participants were classified into asymptomatic, prodromal AD and AD dementia, based on neurologist's judgment blinded to neuropsychological data (Cambridge Cognitive Examination for Older Adults with Down's syndrome [CAMCOG-DS] and modified Cued Recall Test [mCRT]). We compared the cutoffs derived from the normative data in young adults with DS to those from receiveroperating characteristic curve (ROC) analysis. Results: Diagnostic performance of the CAMCOG-DS and modified Cued Recall Test (mCRT) in subjects with mild and moderate levels of intellectual disability (ID) was high, both for diagnosing prodromal AD and AD dementia (area under the curve [AUC] 0.73- 0.83 and 0.90-1, respectively). The cutoffs derived from the normative data were similar to those derived from the ROC analyses. Discussion: Diagnosing prodromal AD and AD dementia in DS with mild and moderate ID using population norms for neuropsychological tests is possible with high diagnostic accuracy.
dc.format
application/pdf
dc.publisher
John Wiley & Sons
dc.relation
Reproducció del document publicat a: https://doi.org/10.1002/dad2.12047
dc.relation
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020, vol. 12, num. 1, p. e12047
dc.relation
https://doi.org/10.1002/dad2.12047
dc.rights
cc-by-nc (c) Benejam, Bessy et al., 2020
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Síndrome de Down
dc.subject
Malaltia d'Alzheimer
dc.subject
Teràpia cognitiva
dc.subject
Tests neuropsicològics
dc.subject
Anàlisi de conducta
dc.subject
Alzheimer's disease
dc.subject
Cognitive therapy
dc.subject
Neuropsychological tests
dc.subject
Behavioral assessment
dc.title
Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion